These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
160 related articles for article (PubMed ID: 19952950)
21. [Sarcoidosis, myasthenia gravis and anterior ischaemic optic neuropathy: severe side effects of adjuvant interferon-alpha-therapy in malignant melanoma?]. Kreutzer K; Bonnekoh B; Franke I; Ulrich J; Gollnick H J Dtsch Dermatol Ges; 2004 Aug; 2(8):689-94. PubMed ID: 16279234 [TBL] [Abstract][Full Text] [Related]
22. [Tolerance and feasibility of adjuvant treatment of stage II malignant melanoma with high-dose interferon-alpha]. Bédane C; Le Brun V; Boulinguez S; Berdah JF; Bouyssou ML; Delpuget N; Bernard P; Tubiana-Mathieu N; Bonnetblanc JM Ann Dermatol Venereol; 1999 Feb; 126(2):142-6. PubMed ID: 10352829 [TBL] [Abstract][Full Text] [Related]
23. The relationship between alexithymia and salivary cortisol levels in somatoform disorders. Pedrosa Gil F; Bidlingmaier M; Ridout N; Scheidt CE; Caton S; Schoechlin C; Nickel M Nord J Psychiatry; 2008; 62(5):366-73. PubMed ID: 18752108 [TBL] [Abstract][Full Text] [Related]
24. Early fluoxetine treatment of post-stroke depression--a three-month double-blind placebo-controlled study with an open-label long-term follow up. Fruehwald S; Gatterbauer E; Rehak P; Baumhackl U J Neurol; 2003 Mar; 250(3):347-51. PubMed ID: 12638027 [TBL] [Abstract][Full Text] [Related]
25. Depressive symptoms after initiation of interferon therapy in human immunodeficiency virus-infected patients with chronic hepatitis C. Laguno M; Blanch J; Murillas J; Blanco JL; León A; Lonca M; Larrousse M; Biglia A; Martinez E; García F; Miró JM; de Pablo J; Gatell JM; Mallolas J Antivir Ther; 2004 Dec; 9(6):905-9. PubMed ID: 15651749 [TBL] [Abstract][Full Text] [Related]
26. One year cumulative incidence of depression following myocardial infarction and impact on cardiac outcome. Strik JJ; Lousberg R; Cheriex EC; Honig A J Psychosom Res; 2004 Jan; 56(1):59-66. PubMed ID: 14987965 [TBL] [Abstract][Full Text] [Related]
27. Interferon-alpha influences tryptophan metabolism without inducing psychiatric side effects. Bannink M; Fekkes D; Van Gool AR; Kruit WH; Sleijfer S; van der Holt B; Eggermont AM; Stoter G; Hengeveld MW Neuropsychobiology; 2007; 55(3-4):225-31. PubMed ID: 17873497 [TBL] [Abstract][Full Text] [Related]
28. Addressing tri-morbidity (hepatitis C, psychiatric disorders, and substance use): the importance of routine mental health screening as a component of a comanagement model of care. Fireman M; Indest DW; Blackwell A; Whitehead AJ; Hauser P Clin Infect Dis; 2005 Apr; 40 Suppl 5():S286-91. PubMed ID: 15768336 [TBL] [Abstract][Full Text] [Related]
29. The effect of adjunctive light therapy on ameliorating breakthrough depressive symptoms in adolescent-onset bipolar disorder. Papatheodorou G; Kutcher S J Psychiatry Neurosci; 1995 May; 20(3):226-32. PubMed ID: 7786884 [TBL] [Abstract][Full Text] [Related]
30. [Intensity of depression in pedagogy students]. Pietras T; Witusik A; Panek M; Zielińska-Wyderkiewicz E; Kuna P; Górski P Pol Merkur Lekarski; 2012 Mar; 32(189):163-6. PubMed ID: 22568180 [TBL] [Abstract][Full Text] [Related]
31. Self-efficacy for coping with cancer in melanoma patients: its association with physical fatigue and depression. Albrecht K; Droll H; Giesler JM; Nashan D; Meiss F; Reuter K Psychooncology; 2013 Sep; 22(9):1972-8. PubMed ID: 23288588 [TBL] [Abstract][Full Text] [Related]
32. Interferon-alpha in oncology patients: fewer psychiatric side effects than anticipated. Bannink M; Kruit WH; Van Gool AR; Sleijfer S; van der Holt B; Eggermont AM; Stoter G; Hengeveld MW Psychosomatics; 2008; 49(1):56-63. PubMed ID: 18212177 [TBL] [Abstract][Full Text] [Related]
33. A prospective study of cutaneous adverse events induced by low-dose alpha-interferon treatment for malignant melanoma. Guillot B; Blazquez L; Bessis D; Dereure O; Guilhou JJ Dermatology; 2004; 208(1):49-54. PubMed ID: 14730237 [TBL] [Abstract][Full Text] [Related]
34. Adjuvant therapy of melanoma with interferon-alpha-2b is associated with mania and bipolar syndromes. Greenberg DB; Jonasch E; Gadd MA; Ryan BF; Everett JR; Sober AJ; Mihm MA; Tanabe KK; Ott M; Haluska FG Cancer; 2000 Jul; 89(2):356-62. PubMed ID: 10918166 [TBL] [Abstract][Full Text] [Related]
35. Mood changes, depression and suicide risk during isotretinoin treatment: a prospective study. Nevoralová Z; Dvořáková D Int J Dermatol; 2013 Feb; 52(2):163-8. PubMed ID: 23347302 [TBL] [Abstract][Full Text] [Related]
36. Neurobehavioral effects of interferon-alpha in cancer patients: phenomenology and paroxetine responsiveness of symptom dimensions. Capuron L; Gumnick JF; Musselman DL; Lawson DH; Reemsnyder A; Nemeroff CB; Miller AH Neuropsychopharmacology; 2002 May; 26(5):643-52. PubMed ID: 11927189 [TBL] [Abstract][Full Text] [Related]
37. Cognitive impairment in patients with chronic hepatitis treated with interferon alpha (IFNalpha): results from a prospective study. Lieb K; Engelbrecht MA; Gut O; Fiebich BL; Bauer J; Janssen G; Schaefer M Eur Psychiatry; 2006 Apr; 21(3):204-10. PubMed ID: 16632167 [TBL] [Abstract][Full Text] [Related]
38. Prediction of the depressive effects of interferon alfa therapy by the patient's initial affective state. Capuron L; Ravaud A N Engl J Med; 1999 Apr; 340(17):1370. PubMed ID: 10223879 [No Abstract] [Full Text] [Related]
39. Can antidepressants prevent interferon-alpha-induced depression? A review of the literature. Galvão-de Almeida A; Guindalini C; Batista-Neves S; de Oliveira IR; Miranda-Scippa A; Quarantini LC Gen Hosp Psychiatry; 2010; 32(4):401-5. PubMed ID: 20633744 [TBL] [Abstract][Full Text] [Related]
40. Alopecia areata induced by adjuvant treatment with alpha-interferon in malignant melanoma? Radny P; Bauer J; Caroli UM; Eigentler TK; Kamin A; Metzler G; Garbe C Dermatology; 2004; 209(3):249-50. PubMed ID: 15459547 [No Abstract] [Full Text] [Related] [Previous] [Next] [New Search]